The addition of a new distribution partner in Europe devoted to Ingevity's Capa biodegradable thermoplastics allows the company to better service its customers in the region. Ultrapolymers' network of compounders and converters, as well as its technical competence and customer service, are consistent with Ingevity's growth strategy in Europe. Image Source: Zacks Investment Research Ingevity, in February 2019, completed the purchase of the Capa caprolactone division of Perstorp Holding AB for roughly $652.5 ...

Ingevity Corporation (NYSE:NGVT) Q1 2024 Earnings Conference Call May 2, 2024 10:00 AM ET Company Participants John Nypaver - Vice President of Investor Relations & Treasurer John Fortson - President & Chief Executive Officer Mary Hall - Chief Financial Officer Rich White - President, Performance Chemicals Ed Woodcock - President, Performance Materials Conference Call Participants Vincent Anderson - Stifel Daniel Rizzo - Jefferies John McNulty - BMO Capital Markets Ian Zaffino - Oppenheimer Jon Tanwanteng - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 ______________________ ...

5 Capital allocation Net Debt Ratio and Trailing Twelve Months (TTM) Adj. EBITDA (1) | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |---------|----------------------|---------|-----------------------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------|-------------------------|---------------|------------------------------|------------- ...

For the quarter ended March 2024, Ingevity (NGVT) reported revenue of $340.1 million, down 13.4% over the same period last year. EPS came in at $0.52, compared to $1.09 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $319.85 million, representing a surprise of +6.33%. The company delivered an EPS surprise of +40.54%, with the consensus EPS estimate being $0.37.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Ingevity (NGVT) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $1.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40.54%. A quarter ago, it was expected that this company would post a loss of $0.13 per share when it actually produced earnings of $0.21, delivering a surprise of 261.54%.Over the last four quarters, the company has surp ...

Exhibit 99.1 News Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Contact: Caroline Monahan 843-740-2068 media@ingevity.com Investors: John E. Nypaver, Jr. 843-740-2002 investors@ingevity.com Ingevity reports first quarter 2024 financial results HIGHLIGHTS: (comparisons versus prior year period) The results and guidance in this release include non-GAAP financial measures. Refer to the section entitled "Use of non- GAAP financial measures" within this release ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-K ______________________________________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-375 ...

Ingevity Corporation (NYSE:NGVT) Q4 2023 Earnings Conference Call February 22, 2024 9:00 AM ET Company Participants John Nypaver - Vice President of Investor Relations & Treasurer John Fortson - President & Chief Executive Officer Mary Hall - Chief Financial Officer Ed Woodcock - President, Performance Materials Conference Call Participants Vincent Anderson - Stifel Jon Tanwanteng - CJS Securities Mike Sison - Wells Fargo Daniel Rizzo - Jefferies Operator Hello, and welcome to the Ingevity Fourth Quarter an ...

February 22, 2024 1 Full year summary Consolidated financial results 3 4 Guidance ingevity FULL YEAR SUMMARY Road Technologies business line, previously named Pavement Technologies, reported record sales for the year Sales declined versus the prior year driven by lower volumes in APT and Industrial Specialties which more than offset higher volume in Performance Materials and Road Technologies Sales were up 1% due primarily to increased pricing across all segments and the addition of Ozark, offsetting volume ...